SCHEMBL3676873

SCHEMBL3676873

CC1CCN(C(CCC=O)c2ccc(F)cc2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.40
MAPT P10636 2/20 0.39
KCNH2 Q12809 4/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CHRM2 P08172 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA2A P08913 1/20 0.38
DRD1 P21728 1/20 0.38
ADRA1A P35348 1/20 0.38
OPRM1 P35372 1/20 0.38
DRD3 P35462 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
ALDH1A1 P00352 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20529619 1.00 TSHR (0.40) TSHRMAPTKCNH2MEN1KMT2A
SCHEMBL16225988 0.73 ACHE (0.51) TSHRMAPTKCNH2MEN1KMT2A
Hydrochloric Acid SCHEMBL5199132 0.72 MMP2 (0.37) TSHRMAPTLMNATP53SIGMAR1
SCHEMBL11399201 0.71 P2RX7 (0.37) KCNH2OPRM1DPP4DPP8DPP7
SCHEMBL23883211 0.71 DRD2 (0.55) TSHRKCNH2MEN1KMT2ACHRM2
SCHEMBL5820396 0.71 DRD2 (0.55) TSHRKCNH2MEN1KMT2ACHRM2
SCHEMBL10371232 0.71 MEN1 (0.35) TSHRMEN1KMT2ATP53
SCHEMBL27999842 0.68 HTT (0.37) MEN1KMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL12513634 0.67 SLC6A2 (0.54) TSHRKCNH2MEN1KMT2AOPRM1
SCHEMBL67251 0.67 CYP19A1 (0.41) MEN1KMT2ANPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2175724-A1 METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA USING ANTIPSYCHOTIC COMBINATION THERAPY Medivation Neurology, Inc. (US) 2010-04-21 EP disclosed
WO-2009017836-A1 METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA USING ANTIPSYCHOTIC COMBINATION THERAPY MEDIVATION NEUROLOGY, INC. (US) 2009-02-05 WO disclosed
EP-1565184-A1 TREATMENT OF HEADACHE WITH ANTIPSYCHOTICS DELIVERED BY INHALATION Alexza Molecular Delivery Corporation (US) 2005-08-24 EP disclosed
WO-2004047841-A1 TREATMENT OF HEADACHE WITH ANTIPSYCHOTICS DELIVERED BY INHALATION ALEXZA MOLECULAR DELIVERY CORPORATION (US) 2004-06-10 WO disclosed